A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Iron Dextran
Terlipressin
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Terlipressin.
Iron Dextran
Aceprometazine
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Aceprometazine.
Iron Dextran
Probucol
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Probucol.
Iron Dextran
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Mibefradil.
Iron Dextran
Papaverine
The risk or severity of QTc prolongation can be increased when Papaverine is combined with Mibefradil.
Iron Dextran
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Mibefradil.
Iron Dextran
Mesoridazine
The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Mibefradil.
Iron Dextran
Lithium cation
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Lithium cation.
Iron Dextran
Ribociclib
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Ribociclib.
Iron Dextran
Macimorelin
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Macimorelin.
Iron Dextran
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Deutetrabenazine.
Iron Dextran
Glasdegib
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Glasdegib.
Iron Dextran
Lumefantrine
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Lumefantrine.
Iron Dextran
Artemether
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Artemether.
Iron Dextran
Asenapine
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Asenapine.
Iron Dextran
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Tetrabenazine.
Iron Dextran
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Zuclopenthixol.
Iron Dextran
Temafloxacin
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Temafloxacin.
Iron Dextran
Halofantrine
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Halofantrine.
Iron Dextran
Magnesium salicylate
The risk or severity of hypotension can be increased when Magnesium salicylate is combined with Mibefradil.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3